A continuing role for sweat testing in an era of newborn screening for cystic fibrosis

Clinical Biochemistry

Volumn 44, Issue 7, 2011, Pages 487-488

  Kirk, Jean M ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC TEST; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFANT; MUTATIONAL ANALYSIS; NEWBORN SCREENING; PRIORITY JOURNAL; SWEAT TEST;

CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTRIC CONDUCTIVITY; FEMALE; GENETIC TESTING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; MUTATION; NEONATAL SCREENING; SCOTLAND; SEQUENCE ANALYSIS, DNA; SODIUM; SWEAT; SWEATING; TRYPSIN;

EID: 79955142315     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.02.019     Document Type: Article

References (4)

1. Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J Inher Metab Dis 2007, 30:537-543.
2. Cystic Fibrosis Mutation Database Accessed. http://www.genet.sickkids.on.ca/cftr/.
3. Green A., Kirk J. Guidelines for the performance of the sweat test in the diagnosis of cystic fibrosis. Ann Clin Biochem 2007, 44:25-34.
4. De Boeck K., Wilschanski M., Castellani C., Taylor C., Cuppens H., Dodge J., Sinaasappel M. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006, 61:627-635.